2. Academic Validation
  3. Bidirectional modulation of HIF-2 activity through chemical ligands

Bidirectional modulation of HIF-2 activity through chemical ligands

  • Nat Chem Biol. 2019 Apr;15(4):367-376. doi: 10.1038/s41589-019-0234-5.
Dalei Wu 1 2,  Xiaoyu Su 3,  Jingping Lu 3,  Sheng Li 4,  Becky L Hood 5,  Stefan Vasile 5,  Nalini Potluri 3,  Xiaotong Diao 6,  Youngchang Kim 7,  Sepideh Khorasanizadeh 3 8,  Fraydoon Rastinejad 9 10
Affiliations

Affiliations

  • 1 Helmholtz International Lab, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China. [email protected].
  • 2 Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA. [email protected].
  • 3 Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA.
  • 4 Department of Medicine and UCSD DXMS Proteomics Resource, University of California, San Diego, La Jolla, CA, USA.
  • 5 Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA.
  • 6 Helmholtz International Lab, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
  • 7 Structural Biology Center, Biosciences Division, Argonne National Laboratory, Argonne, IL, USA.
  • 8 Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • 9 Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA. [email protected].
  • 10 Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. [email protected].
PMID: 30804532 DOI: 10.1038/s41589-019-0234-5
Abstract

Hypoxia-inducible factor-2 (HIF-2) is a heterodimeric transcription factor formed through dimerization between an oxygen-sensitive HIF-2α subunit and its obligate partner subunit ARNT. Enhanced HIF-2 activity drives some cancers, whereas reduced activity causes anemia in chronic kidney disease. Therefore, modulation of HIF-2 activity via direct-binding ligands could provide many new therapeutic benefits. Here, we explored HIF-2α chemical ligands using combined crystallographic, biophysical, and cell-based functional studies. We found chemically unrelated antagonists to employ the same mechanism of action. Their binding displaced residue M252 from inside the HIF-2α PAS-B pocket toward the ARNT subunit to weaken heterodimerization. We also identified first-in-class HIF-2α agonists and found that they significantly displaced pocket residue Y281. Its dramatic side chain movement increases heterodimerization stability and transcriptional activity. Our findings show that despite binding to the same HIF-2α PAS-B pocket, ligands can manifest as inhibitors versus activators by mobilizing different pocket residues to allosterically alter HIF-2α-ARNT heterodimerization.

Figures
Products